Koide, Yutaro
Nagai, Naoya
Adachi, Sou
Ito, Masayuki
Kawamura, Mariko
Ito, Makoto
Ito, Fumitaka
Shindo, Yurika
Aoyama, Takahiro
Shimizu, Hidetoshi
Hashimoto, Shingo
Tachibana, Hiroyuki
Kodaira, Takeshi
Funding for this research was provided by:
Japan Society for the Promotion of Science (23K14669)
Article History
Received: 26 March 2024
Accepted: 15 April 2024
First Online: 22 April 2024
Declarations
:
: YK has a speaker’s bureau for Hitachi Co., Global Breast Cancer Conference (GBCC), and received research funding from Japan Society for the Promotion of Science (JSPS, Grant Number 23K14669). MK has a research grant from Accuray Co. and speaker’s bureau for Accuray Co., Chugai Pharmaceutical, and leadership/fiduciary roles in Japanese Society for Radiation Oncology (educational committee, public relations committee, international committee), Japanese Breast cancer society (educational committee, guideline committee), and Japan Radiological Society (international committee, diversity committee). TK has a speaker’s bureau for Hitachi Co., Bristol Myers Squibb., Accuray Co., Elekta Co., Ono Pharmaceutical Co., AstraZeneca Co., Taiho Pharmaceutical Co., Canon Co., and Janssen Pharmaceutical Co.